Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 98.84M P/E - EPS this Y 24.90% Ern Qtrly Grth -
Income -49.35M Forward P/E -2.95 EPS next Y 3.40% 50D Avg Chg -6.00%
Sales 19.05M PEG - EPS past 5Y - 200D Avg Chg -14.00%
Dividend N/A Price/Book 1.33 EPS next 5Y - 52W High Chg -50.00%
Recommedations 1.70 Quick Ratio 2.61 Shares Outstanding 29.92M 52W Low Chg 18.00%
Insider Own 14.58% ROA -31.39% Shares Float 24.10M Beta 1.51
Inst Own 29.99% ROE -71.67% Shares Shorted/Prior 1.49M/1.47M Price 3.69
Gross Margin 51.02% Profit Margin -282.37% Avg. Volume 113,364 Target Price 5.67
Oper. Margin -310.09% Earnings Date Aug 8 Volume 197,335 Change 0.27%
About DarioHealth Corp.

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

DarioHealth Corp. News
06/25/24 Dario Demonstrates 12 Months of Sustained Healthy Behavior Change for Members Taking a GLP-1
06/05/24 Empowering Commercial Expansion: DarioHealth Announces Strategic Reorganization and Appoints Inaugural Chief Commercial Officer
05/16/24 DarioHealth Corp (DRIO) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and ...
05/15/24 DarioHealth Corp. (DRIO) Reports Q1 Loss, Misses Revenue Estimates
05/15/24 DarioHealth Reports First Quarter 2024 Financial and Operating Results
05/07/24 DarioHealth to Report First Quarter 2024 Results on Wednesday, May 15th
04/25/24 Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes
04/18/24 Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution
04/10/24 Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health
04/02/24 Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health
04/01/24 DarioHealth Corp. (NASDAQ:DRIO) Q4 2023 Earnings Call Transcript
05:30 AM DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results
03/24/24 11 Best Small Cap AI Stocks To Buy Now
03/21/24 DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH
03/12/24 New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications
08:30 AM DARIOHEALTH TO PARTICIPATE IN THE COWEN 43RD ANNUAL HEALTHCARE CONFERENCE
02/22/24 DarioHealth acquires fellow digital health firm Twill
02/21/24 Today's Schedule at The MicroCap Rodeo Winter Wrap Up Conference
02/21/24 Dario acquires Twill creating one of the most comprehensive digital health platform across the most prevalent chronic conditions
01/22/24 Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET
DRIO Chatroom

User Image ConnectionIsLife Posted - 1 day ago

$DRIO Such great discounts at these levels - can't hate on you sellers. Never look a gift horse in the mouth as they say...

User Image ConnectionIsLife Posted - 1 day ago

$DRIO And now DRIO releases a new white paper on understanding the market. What is the short argument again? Haha... https://letstalk.dariohealth.com/true-value-of-digital-health?utm_campaign=2024-Affordability%20and%20Tech%20in%20Digital%20Health&utm_source=linkedin&utm_medium=social&utm_content=link-in-comments

User Image ConnectionIsLife Posted - 1 day ago

$DRIO Talk about the entire healthcare market coming DRIOs way...."How to cut costs and improve consumer experience in healthcare" from CVS. How does it feel to be trapped within a .20 cent window swing traders? Your short seller really looking out for your interests? Talking about fiddle playing while your con is burning. Haha... P.S. Tick tock shorts...the clock is inevitability if you own shares like me :-) https://www.forbes.com/sites/forbesbusinesscouncil/2024/02/23/how-to-cut-costs-and-improve-the-consumer-healthcare-experience-in-2024/

User Image Gilac Posted - 2 days ago

$DRIO a fantastic recap of the GLP-1 status. long but worth reading. https://ro.co/perspectives/worst-it-will-ever-be/

User Image ConnectionIsLife Posted - 2 days ago

$DRIO Note the pattern CVS is setting...clinical studies for payers to adopt the behavior modifying programs that save payers money. Why? Because it looks like CVS is starting to make a business translating digital to insurance coverage. The stock price is the feint folks...the "prestige" so to speak. Know what you own. https://www.helloheart.com/press/study-in-the-journal-of-the-american-heart-association-links-hello-heart-usage-to-significant-reductions-in-blood-pressure-cholesterol-and-weight

User Image ItsAllAboutBeingFirst Posted - 3 days ago

$BARK $drio $rmco 5$ stocks by eoy!!! Huckaberries 😆

User Image StantheMan32 Posted - 3 days ago

@Cutlass Rachel holding big bags on $DRIO, $CRDF, $GANX That's not a strategy girl $XBI

User Image STCG Posted - 3 days ago

$DRIO so what are your thoughts on the $1.18 wall? someone selling borrowed shares? someone wanting out? a fake wall that mostly disappears when being sold?

User Image OpenOutcrier Posted - 3 days ago

$DRIO (+5.0% pre) Dario Demonstrates 12 Months of Sustained Healthy Behavior Change for Members Taking a GLP-1 - SI https://ooc.bz/l/36242

User Image printcomm Posted - 4 days ago

$DRIO Can't you close green 2 days in a row?

User Image GeorgeLanesGhost Posted - 6 days ago

$DRIO Summer solistice upon us Triple bottom reached on 6/13, 18, 20. Next resistence at $1.38

User Image printcomm Posted - 1 week ago

$DRIO We have a buyer!

User Image printcomm Posted - 1 week ago

$DRIO It's alive!

User Image Big_Baggies Posted - 1 week ago

$DRIO down 40% in a month and yet nobody is buying at $1.10. They know.

User Image peugout505 Posted - 1 week ago

@STCG great post, thank you. Holding 42k shares at $4.65 avg since 2020. Bought the entire way up and down. $DRIO shouldn't have IPO'd as it has zero revenue traction. We're obviously early. Contract after contract / partnership announcements without ANY revenue performance, minus crumbs + BS research "partnerships", masked as marketing validation for $SNY. CRO just swapped out, goalposts moved. While thesis sounds strong: software/hardware/consumer flywheel of data to improve conditions - business is UNPROVEN. Anyone have clear path to revenue to share? Seriously- chart is a path to $5 share price. I'm close to dumping it all to buy $ZVRA on the run up to FDA approval in Sept...

User Image STCG Posted - 1 week ago

$DRIO Not that anyone cares, but here is where I sit on DRIO. The company Acquires Upright for 31M, Acquires twill for 30M, Acquires AI enables PHYsimax for a few Million. gets 30M partnership revenue from $SNY, Expanding SNY partnership (lets see that PR already!). Multiple large partnerships with the blues and other health plans (Aetna). Twil investors invested like 100M+ into Twil and are wanting this to work out so they can get a return on their original Twil investment. DRIO is 20X a better company than they were 5 years ago and the price is 1/20th what it was before all these improvements. Twil helped with revenue. Now need closer to break even. Market cap is only 33M or so? Seems low. But they will need to paint a picture of their runway to cash flow positive. My average is around $1.57 right now. PT is $3.0 to start selling some shares. Holding some for a much higher price target. Not buying more until there is a clear inflection point that the market recognizes.

User Image Big_Baggies Posted - 1 week ago

$DRIO beware of pumpers.

User Image Big_Baggies Posted - 1 week ago

$DRIO Nothing but dilution and a RS ahead for this failing business. Bankruptcy to follow.

User Image STCG Posted - 1 week ago

$DCGO I exited around $3.21. Moving some money over into $DRIO to average down. I think there is a 100% upside in the next 18 months minimum. Rode DCGO up three times for about 6%-10% each run. Will enter again if it approaches $2.85. Now lets see DRIO steady climb through EOY.

User Image StantheMan32 Posted - 1 week ago

@Cutlass You've been wrong here and with $DRIO. Never catch a falling knife

User Image ConnectionIsLife Posted - 1 week ago

$DRIO This share price, 1.16, is so backwards it doesnt even appear to acknowledge the Twill purchase/merger........ .....can't see how this maintains in run up to early August earnings. not trading advice. Just pointing out the dynamics which are clearly against our shorts/bears.

User Image Aegis7410 Posted - 2 weeks ago

$DRIO I wish I had dry powder to buy at these levels. My average is still a bit high

User Image BiotechPsycho Posted - 2 weeks ago

$DRIO @JaguarCapitalLLC want to dip their balls into the fire with a new report ?

User Image TheLearnerEarner Posted - 2 weeks ago

$DRIO added QUALITY BARGAIN stock swing trade - healthcare - micro cap - 1/9 F-Score - 1.69x relative volume - excellent intrinsic value potential - 2x analysts buy rating - revenue is forecast to grow 37.6% per year - trading at 95.2% below estimate of its fair value - short term gains (with potential for a medium term upgrade) 💱 RSI: 33.12 (oversold bullish) 📊 Analyst Price Target: $4.50 - $8.00 (298.23% - 607.96% above Price) 🌟 Range (12m) $0.68 - $4.26 💰 NEWSDESK (last recent article) 📰 https://finance.yahoo.com/news/empowering-commercial-expansion-dariohealth-announces-123000159.html

User Image ConnectionIsLife Posted - 2 weeks ago

$DRIO For what its worth, a trading thesis....the patterns match the description below. It still looks like an environment and set up for a more bullish stock price (one way or another) coming this year. Not trading advice. Just musing out loud.

User Image ConnectionIsLife Posted - 2 weeks ago

$DRIO When you are the company disrupting with A.I. in healthcare patient care - THE DISRUPTOR - you are going to get delayed with regulators. That happened last year. Key behavioral read - they are EXANDING their deals now with multiple national payers. There are only a few of those. Another - Obviously Twill saw that which is why they SOLD TO DRIO. Why would Twill sell-merge to DRIO after they saw the books if this ship was sinking? And why would the big insurance plans be expanding? I keep buying at these levels. Its crazy. Not trading advice. Thanks for discounts.

User Image BiotechPsycho Posted - 2 weeks ago

$DRIO covered at 1.01

User Image jt284 Posted - 2 weeks ago

$DRIO next R/s ?

User Image ConnectionIsLife Posted - 2 weeks ago

$DRIO Its options deadline week. These weird shorts pop up every time with this overshare on when they are going to sell. and encourage you should too. its tired keinbock. and running out of runway… but on that, how does it feel to know you are only smart enough to pull off someone else’s? You sir are no Jack Kennedy

User Image Big_Baggies Posted - 2 weeks ago

$DRIO or perhaps it's just a family office selling. I hear that's common around here.

Analyst Ratings
Stifel Buy Apr 1, 24
Alliance Global Partners Buy Aug 11, 23
Stifel Buy Jul 25, 23
Craig-Hallum Buy May 12, 23
Alliance Global Partners Buy Nov 16, 22
Aegis Capital Buy Aug 18, 22
Cowen & Co. Outperform Aug 16, 22
Aegis Capital Buy May 16, 22
Cowen & Co. Outperform May 16, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Raphael Erez Chief Executive Offi.. Chief Executive Officer Jan 13 Sell 6.2075 1,200 7,449 1,112,059 01/18/23
Raphael Erez Chief Executive Offi.. Chief Executive Officer Nov 05 Sell 19.06 1,000 19,060 838,259 11/09/21
Raphael Erez Chief Executive Offi.. Chief Executive Officer Nov 03 Sell 18.73 38,340 718,108 839,259 11/05/21